Incannex granted meeting with FDA over CBD drug cocktail

Retrieved on: 2021-03-26 00:33:45

Tags for this article:

Medical specialties

Health

Medicine

Intensive care medicine

Primary alcohols

Clinical research

Drug discovery

Pharmaceutical industry

Acute respiratory distress syndrome

Ards

Treatment and management of COVID-19

Food and Drug Administration

Incannex Healthcare

Click the tags to see associated articles and topics

Incannex granted meeting with FDA over CBD drug cocktail. View article details on HISWAI: https://stockhead.com.au/health/incannex-granted-meeting-with-fda-over-cbd-drug-cocktail/

Excerpt

Special Report: Incannex Healthcare (ASX:IHL) is making steady progress on its hydroxychloroquine (HCQ)/cannabidiol (CBD) drug combination and ...

Article found on: stockhead.com.au

View Original Article